Hypofractionation in Prostate Cancer Using Proton Beam
Prostate cancer is the most prevalent cancer among men, with an estimated 175,000 new diagnoses in the United States in 2019. A variety of treatment options are available, including active surveillance, radiation therapy, or radical prostatectomy. The choice of treatment modality is based on a number of considerations: risk group, age, comorbidities, and performance status. Shared decision making and informed consent plays a pivotal role in the type of treatment a patient pursues. Patients must understand not only the cancer-related outcomes for their particular situation, but also the anticipated side effects of treatment.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Thomas J. Quinn, Daniel Hamstra Tags: Clinical Investigation Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Physics | Prostate Cancer | Prostatectomy | Radiation Therapy | Radiology | USA Health